1. Home
  2. FT vs ARCT Comparison

FT vs ARCT Comparison

Compare FT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Universal Trust

FT

Franklin Universal Trust

HOLD

Current Price

$8.26

Market Cap

199.8M

Sector

Finance

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$7.21

Market Cap

192.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FT
ARCT
Founded
1988
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
199.8M
192.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FT
ARCT
Price
$8.26
$7.21
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$38.44
AVG Volume (30 Days)
63.0K
434.6K
Earning Date
01-01-0001
03-05-2026
Dividend Yield
7.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$97,601,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.97
$5.85
52 Week High
$7.23
$24.17

Technical Indicators

Market Signals
Indicator
FT
ARCT
Relative Strength Index (RSI) 71.67 47.67
Support Level $8.08 $7.00
Resistance Level $8.10 $7.68
Average True Range (ATR) 0.07 0.44
MACD 0.01 -0.02
Stochastic Oscillator 73.98 22.11

Price Performance

Historical Comparison
FT
ARCT

About FT Franklin Universal Trust

Franklin Universal Trust is a closed-end management investment company focused on providing high current income while preserving capital. Its secondary objective is to achieve income growth through dividend increases and capital appreciation. The fund invests in two asset classes: high-yield bonds and utility stocks. It applies fundamental research to build a diversified high-yield bond portfolio and targets utility companies with attractive dividend yields and a history of increasing dividends.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: